The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Abstract
The past decade has witnessed hundreds of reports declaring or refuting genetic association with putative Alzheimer disease susceptibility genes. This wealth of information has become increasingly difficult to follow, much less interpret. We have created a publicly available, continuously updated database that comprehensively catalogs all genetic association studies in the field of Alzheimer disease (http://www.alzgene.org). We performed systematic meta-analyses for each polymorphism with available genotype data in at least three case-control samples. In addition to identifying the epsilon4 allele of APOE and related effects, we pinpointed over a dozen potential Alzheimer disease susceptibility genes (ACE, CHRNB2, CST3, ESR1, GAPDHS, IDE, MTHFR, NCSTN, PRNP, PSEN1, TF, TFAM and TNF) with statistically significant allelic summary odds ratios (ranging from 1.11-1.38 for risk alleles and 0.92-0.67 for protective alleles). Our database provides a powerful tool for deciphering the genetics of Alzheimer disease, and it serves as a potential model for tracking the most viable gene candidates in other genetically complex diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the main genetic risk factor in SAD is the APOE gene [91,92,93,94].”
From Alzheimer's Disease: Treatment Strategies and Their Limitations. (2022) · cites this paper as [91]
In the citing paper
“Genome-wide association studies have identified BIN1 within the second most significant susceptibility locus in late-onset Alzheimer’s disease (AD).”
From Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts (2016) · cites this paper as [25]
In the citing paper
“Fifty-two sex-specific KNDs of AD were also known AD genetic risk factors based on the AlzGene database and the genes identified from a large-scale meta-analysis carried out by the International Genomics of Alzheimer’s Project (IGAP)”
From Sex specific molecular networks and key drivers of Alzheimer’s disease (2023) · cites this paper as [46]
In the citing paper
“CLU also known as apolipoprotein J (APOJ), was identified as an AD risk gene by a large scale meta-analysis [46].”
From Sex specific molecular networks and key drivers of Alzheimer’s disease (2023) · cites this paper as [46]
In the citing paper
“Among the AD susceptibility genes/loci identified to date, APOE remains the most significant genetic risk factor across populations.”
From Association of rare APOE missense variants with Alzheimer's disease in the Japanese population (2025) · cites this paper as [9]
In the citing paper
“there is a strong positive correlation between the APOE ε4 allele and Aβ pathology in human AD brains with the highest Aβ burden found in homozygous APOE ε4 carriers”
From ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease (2022) · cites this paper as Bertram et al 2007
In the citing paper
“Since then, numerous studies have confirmed that possession of the ε4 allele is the strongest genetic risk factor for both AD and CAA, or a combination of both disorders (Bertram et al., 2007; Farrer et al., 1997).”
From The role of apolipoprotein E in Alzheimer's disease (2009) · cites this paper as Bertram et al., 2007
In the citing paper
“Bridging integrator 1 (BIN1) has been identified as the most important genetic risk factor in LOAD after APOE [475].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [475]
In the citing paper
“In the most common form of AD, sporadic late-onset AD, many genetic variations contribute to increase or lower risk; greater than 20 have been identified (AlzGene Database; www.alzgene.org).22”
From The Alzheimer’s Disease Clinical Spectrum (2019) · cites this paper as [22]
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Comparison of two methods to detect publication bias in meta-analysis.
Peters, J. L. (2006) · JAMA · doi:10.1001/jama.295.6.676 · Cited by 2,278
Lohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S., & Hirschhorn, J. N. (2003) · Nature Genetics · doi:10.1038/ng1071 · Cited by 1,900
Replication validity of genetic association studies
Ioannidis, J. P. A., Ntzani, E., Trikalinos, T. A., & Contopoulos‐Ioannidis, D. G. (2001) · Nature Genetics · doi:10.1038/ng749 · Cited by 1,834
Use and misuse of population attributable fractions
Rockhill, B., Newman, B., & Weinberg, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.1.15 · Cited by 1,683
A comprehensive review of genetic association studies
Hirschhorn, J. N., Lohmueller, K., Byrne, E., & Hirschhorn, K. (2002) · Genetics in Medicine · doi:10.1097/00125817-200203000-00002 · Cited by 1,674
Problems of reporting genetic associations with complex outcomes
Colhoun, H. M., McKeigue, P., & Smith, G. D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12715-8 · Cited by 1,203
The occurrence of lung cancer in man.
Ml, L. (1953) · PubMed · Cited by 945
Meta-analysis of genetic association studies
Munafo, M. R., & Flint, J. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.06.014 · Cited by 637
A method for meta-analysis of molecular association studies
Thakkinstian, A., McElduff, P., D’Este, C. A., Duffy, D. L., & Attia, J. (2004) · Statistics in Medicine · doi:10.1002/sim.2010 · Cited by 615
'Racial' differences in genetic effects for complex diseases
Ioannidis, J., Ntzani, E., & Trikalinos, T. (2004) · Nature Genetics · doi:10.1038/ng1474 · Cited by 467
Trikalinos, T., Salanti, G., Khoury, M., & Ioannidis, J. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj046 · Cited by 292
PBAT: tools for family-based association studies.
Lange, C., DeMeo, D., Silverman, E. K., Weiss, S. T., & Laird, N. M. (2004) · The American Journal of Human Genetics · doi:10.1086/381563 · Cited by 268
A road map for efficient and reliable human genome epidemiology.
The Human Genome Epidemiology Network and the Network of Investigator Networks, Ioannidis, J. P. A., Gwinn, M., Little, J., Higgins, J. P. T., Bernstein, J. L., Boffetta, P., Bondy, M., Bray, M. S., Brenchley, P. E., et al. (2006) · Nature Genetics · doi:10.1038/ng0106-3 · Cited by 244
Alzheimer's disease: one disorder, too many genes?
Bertram, L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh077 · Cited by 204
Self-citationLehmann, D. J., Cortina-Borja, M., Warden, D. R., Smith, A. D., Sleegers, K., Prince, J. A., van Duijn, C. M., & Kehoe, P. G. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi202 · Cited by 199
Weedon, M. N., Schwarz, P. E. H., Horikawa, Y., Iwasaki, N., Illig, T., Holle, R., Rathmann, W., Selisko, T., Schulze, J., Owen, K. R., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/379285 · Cited by 184
Tanzi, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8593 · Cited by 143
Self-citationFarrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124 · cited 1×
“Based on replication in a large number of studies, the only firmly established genetic susceptibility factor for Alzheimer disease is the e4 allele of APOE (hereafter ' APOE -e4'”
BackgroundAssociation between the interleukin-1α gene and Alzheimer’s disease: a meta-analysis
Rainero, I., Bo, M., Ferrero, M., Valfrè, W., Vaula, G., & Pinessi, L. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.011 · Cited by 79
Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysis
Bo, R. D., Scarlato, M., Ghezzi, S., Boneschi, F. M., Fenoglio, C., Galimberti, G., Galbiati, S., Virgilio, R., Galimberti, D., Ferrarese, C., et al. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.025 · Cited by 68
Lehmann, D., Williams, J., McBroom, J., & Smith, A. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00464-x · Cited by 63
Beffert, U., Arguin, C., & Poirier, J. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00888-x · Cited by 58
Zurutuza, L., Verpillat, P., Raux, G., Hannequin, D., Puel, M., Belliard, S., Michon, A., Pothin, Y., Camuzat, A., Penet, C., et al. (2000) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200513 · Cited by 34
Bracken, M. B. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi200 · Cited by 33
Yang, Q., Khoury, M. J., Friedman, J. M., & Flanders, W. D. (2003) · Epidemiology · doi:10.1097/01.ede.0000040256.22618.12 · Cited by 21
Yasuda, M., Hirono, N., Maeda, K., Imamura, T., Mori, E., & Tanaka, C. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.6.722 · Cited by 20
Wu, X., Kan, D., Cooper, R., & Zhu, X. (2005) · BMC Genetics · doi:10.1186/1471-2156-6-s1-s97 · Cited by 3
Cited by
Sorted by citations
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
Defeating Alzheimer's disease and other dementias: a priority for European science and society
Winblad, B., Amouyel, P., Andrieu, S., Ballard, C., Brayne, C., Brodaty, H., Cedazo-Minguez, A., Dubois, B., Edvardsson, D., Feldman, H., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00062-4 · Cited by 1,676
Epidemiology of Alzheimer disease
Reitz, C., Brayne, C., & Mayeux, R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.2 · Cited by 1,675
Metadata
- Authors
- Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Corresponding author
- Bertram, Lars
- Venue
- Nature Genetics
- Published
- 2007-01
- Volume
- 39
- Issue
- 1
- Pages
- 17-23
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2017079501
- Cited by
- 1,857
- References
- 30
- Citations by year
- 2026: 22 · 2025: 36 · 2024: 71 · 2023: 56 · 2022: 57 · 2021: 60 · 2020: 83 · 2019: 91 · 2018: 109 · 2017: 82 · 2016: 99 · 2015: 82 · 2014: 134 · 2013: 135 · 2012: 144
- FWCI
- 62.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD060726)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- Alzheimer's disease, genetic association studies, susceptibility genes, APOE ε4, polymorphism, case-control study, odds ratio, ACE, CHRNB2, presenilin 1, MTHFR, TFAM, TF
- MeSH terms
- Alzheimer Disease, Humans, Genetic Linkage, Polymorphism, Genetic, Genetic Heterogeneity, Genetic Predisposition to Disease, Databases, Genetic, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
